X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (44567) 44567
Newspaper Article (6309) 6309
Book Review (5972) 5972
Publication (2428) 2428
Newsletter (1677) 1677
Magazine Article (492) 492
Transcript (219) 219
Book Chapter (161) 161
Trade Publication Article (136) 136
Web Resource (98) 98
Conference Proceeding (97) 97
Book / eBook (43) 43
Dissertation (31) 31
Reference (18) 18
Data Set (7) 7
Paper (5) 5
Government Document (4) 4
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (36870) 36870
cholesterol (30561) 30561
humans (29993) 29993
male (23505) 23505
female (19740) 19740
middle aged (16232) 16232
lipids (13397) 13397
adult (12126) 12126
cardiovascular disease (11376) 11376
animals (10442) 10442
risk factors (10262) 10262
cholesterol - blood (9948) 9948
aged (9879) 9879
atherosclerosis (9193) 9193
triglycerides - blood (9144) 9144
cholesterol, hdl - blood (8954) 8954
cholesterol, ldl - blood (8007) 8007
studies (7199) 7199
lipoproteins (6313) 6313
diabetes (5930) 5930
research (5664) 5664
lipids - blood (5613) 5613
low density lipoproteins (5512) 5512
triglycerides (5369) 5369
cardiac & cardiovascular systems (4956) 4956
endocrinology & metabolism (4893) 4893
metabolism (4757) 4757
statins (4713) 4713
abridged index medicus (4628) 4628
pharmacology & pharmacy (4563) 4563
risk (4482) 4482
coronary-heart-disease (4435) 4435
genetics (4370) 4370
health aspects (4369) 4369
analysis (4322) 4322
diet (4283) 4283
rats (4243) 4243
cardiovascular-disease (4213) 4213
nutrition & dietetics (4188) 4188
hypercholesterolemia (4146) 4146
mice (4012) 4012
cardiovascular diseases (3972) 3972
physiological aspects (3957) 3957
obesity (3790) 3790
metabolic syndrome (3751) 3751
biochemistry & molecular biology (3717) 3717
peripheral vascular disease (3572) 3572
body mass index (3550) 3550
blood pressure (3493) 3493
mortality (3489) 3489
care and treatment (3486) 3486
disease (3386) 3386
treatment outcome (3324) 3324
hypertension (3231) 3231
insulin resistance (3203) 3203
glucose (3174) 3174
inflammation (3124) 3124
plasma (3036) 3036
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3005) 3005
cholesterol - metabolism (3002) 3002
blood cholesterol (2946) 2946
low density lipoprotein (2942) 2942
prevention (2937) 2937
coronary heart disease (2924) 2924
medical research (2904) 2904
density-lipoprotein cholesterol (2893) 2893
drug therapy (2863) 2863
insulin-resistance (2729) 2729
type 2 diabetes (2695) 2695
double-blind method (2691) 2691
medicine, general & internal (2621) 2621
hypercholesterolemia - drug therapy (2604) 2604
myocardial-infarction (2603) 2603
liver (2580) 2580
oxidative stress (2572) 2572
biomarkers - blood (2550) 2550
lipoproteins - blood (2549) 2549
medicine (2542) 2542
rodents (2487) 2487
insulin (2486) 2486
cardiovascular (2470) 2470
proteins (2470) 2470
anticholesteremic agents - therapeutic use (2423) 2423
risk-factors (2370) 2370
adolescent (2339) 2339
high-density-lipoprotein (2318) 2318
apolipoproteins (2307) 2307
low-density-lipoprotein (2304) 2304
research article (2303) 2303
liver - metabolism (2269) 2269
lipid metabolism (2260) 2260
c-reactive protein (2227) 2227
blood glucose - metabolism (2216) 2216
time factors (2210) 2210
dyslipidemia (2189) 2189
prospective studies (2179) 2179
hypolipidemic agents - therapeutic use (2177) 2177
heart-disease (2122) 2122
medicine & public health (2093) 2093
prevalence (2091) 2091
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (52858) 52858
German (174) 174
Chinese (157) 157
French (91) 91
Russian (91) 91
Spanish (69) 69
Polish (53) 53
Italian (42) 42
Japanese (38) 38
Hungarian (23) 23
Portuguese (22) 22
Turkish (12) 12
Romanian (8) 8
Czech (7) 7
Korean (7) 7
Ukrainian (7) 7
Dutch (5) 5
Norwegian (5) 5
Finnish (3) 3
Hebrew (3) 3
Slovak (3) 3
Swedish (3) 3
Bulgarian (2) 2
Croatian (2) 2
Danish (2) 2
Indonesian (2) 2
Lithuanian (2) 2
Arabic (1) 1
Bosnian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2009, Volume 54, Issue 19, pp. 1787 - 1794
Objectives: Our aim was to determine the effects of high-dose (2 g) nicotinic acid (NA) on progression of atherosclerosis and measures of vascular function.... 
atherosclerosis | magnetic resonance imaging | carotid | HDL cholesterol | INTIMA-MEDIA THICKNESS | CARDIAC & CARDIOVASCULAR SYSTEMS | CHOLESTEROL | SAFETY | ENDOTHELIAL FUNCTION | HIGH-DENSITY-LIPOPROTEIN | CLINICAL-TRIALS | HIGH-RESOLUTION | DOUBLE-BLIND | NIACIN NIASPAN | CORONARY-HEART-DISEASE | Tunica Media - pathology | Tunica Media - drug effects | Humans | Middle Aged | Tunica Intima - physiopathology | Carotid Artery Diseases - physiopathology | Male | Niacin - pharmacology | Niacin - administration & dosage | Niacin - therapeutic use | Time Factors | Carotid Artery Diseases - pathology | Cholesterol, LDL - blood | Female | Carotid Artery Diseases - drug therapy | Double-Blind Method | Drug Administration Schedule | Cholesterol, HDL - drug effects | Cholesterol, LDL - drug effects | Treatment Outcome | Hypolipidemic Agents - pharmacology | Tunica Intima - drug effects | Magnetic Resonance Imaging | Confounding Factors (Epidemiology) | Tunica Intima - pathology | Hypolipidemic Agents - administration & dosage | Triglycerides - blood | Cholesterol, HDL - blood | Aged | Hypolipidemic Agents - therapeutic use | Tunica Media - physiopathology | Delayed-Action Preparations | Lipoproteins | Nuclear magnetic resonance--NMR | Pulmonary arteries | Coronary vessels | Mortality | Atherosclerosis | Cardiovascular disease | Diabetes | Acute coronary syndromes | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2010, Volume 55, Issue 23, pp. 2580 - 2589
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 03/2015, Volume 17, Issue 3, pp. 294 - 303
Aims: The long-term efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, was evaluated over 104 weeks in patients aged 55-80... 
phase | study | type 2 diabetes | inhibitor | SGLT2 | canagliflozin | III | Phase III study | Type 2 diabetes | Canagliflozin | SGLT2 inhibitor | GLYCEMIC CONTROL | PLACEBO | BACKGROUND METFORMIN | ADD-ON | SITAGLIPTIN | MELLITUS | phase III study | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | POOLED ANALYSIS | GLIMEPIRIDE | INHIBITOR | Thiophenes - therapeutic use | Thiophenes - adverse effects | Humans | Middle Aged | Glycated Hemoglobin A - drug effects | Body Weight - drug effects | Male | Osmolar Concentration | Urinary Tract Infections - chemically induced | Aged, 80 and over | Cholesterol, LDL - blood | Female | Glucosides - therapeutic use | Blood Pressure - drug effects | Metformin - administration & dosage | Glucosides - adverse effects | Hypoglycemic Agents - therapeutic use | Fasting | Double-Blind Method | Cholesterol, HDL - drug effects | Cholesterol, LDL - drug effects | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Diuresis - drug effects | Cholesterol, HDL - blood | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Mycoses - chemically induced | Glucose metabolism | Low density lipoproteins | Mycoses | Hemoglobin | Urinary tract infections | Blood lipids | Glucose | Dextrose | Medical research | Blood pressure | Diabetes | Cholesterol | Index Medicus
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2010, Volume 55, Issue 24, pp. 2721 - 2726
Journal Article
Diabetes Care, ISSN 0149-5992, 06/2009, Volume 32, Issue 6, pp. 1087 - 1091
OBJECTIVE - The purpose of this study was to examine the effects of statin therapy on lipoprotein particle concentrations inpatients with the metabolic... 
TRIAL | PANEL | MAGNETIC-RESONANCE-SPECTROSCOPY | THERAPY | CHOLESTEROL | SUBCLASSES | SIZE | ENDOCRINOLOGY & METABOLISM | LOW-DENSITY-LIPOPROTEIN | RISK | Dyslipidemias - complications | Cholesterol - blood | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Lipoproteins, LDL - drug effects | Placebos | Cholesterol, LDL - blood | Female | Pyrroles - therapeutic use | Apolipoprotein A-I - drug effects | Body Mass Index | Dyslipidemias - drug therapy | Double-Blind Method | Cholesterol, HDL - drug effects | Rosuvastatin Calcium | Cholesterol, LDL - drug effects | European Continental Ancestry Group | Metabolic Syndrome - complications | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cholesterol, HDL - blood | Aged | Fluorobenzenes - therapeutic use | Lipoproteins, LDL - blood | Apolipoprotein A-I - blood | Medical research | Care and treatment | Cardiac patients | Low density lipoproteins | Medicine, Experimental | Rosuvastatin | Research | All terrain vehicles | Coronary heart disease | Cholesterol | Cardiovascular agents | Diseases | Plasma | Nuclear magnetic resonance--NMR | Nutrition | Atoms & subatomic particles | Cardiovascular disease | Metabolic syndrome | Patients | Diet | Risk assessment | Comparative studies | Clinical medicine | Drug therapy | Index Medicus | Original Research
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9992, pp. 452 - 460
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 01/2003, Volume 77, Issue 5, pp. 1146 - 1155
Background: The effects of dietary fats on the risk of coronary artery disease (CAD) have traditionally been estimated from their effects on LDL cholesterol.... 
Carbohydrates | Serum lipoproteins | Diet | Fatty acids | Coronary artery disease risk | carbohydrates | SUNFLOWER OIL | fatty acids | PALMITIC ACID | DENSITY-LIPOPROTEIN-CHOLESTEROL | CORONARY HEART-DISEASE | TRANS-FATTY | HEALTHY-YOUNG MEN | NUTRITION & DIETETICS | PLASMA-LIPIDS | HYDROGENATED SOYBEAN OIL | STEARIC-ACID | coronary artery disease risk | diet | NORMOLIPIDEMIC MEN | serum lipoproteins | Dietary Carbohydrates - administration & dosage | Cardiovascular Diseases - etiology | Fatty Acids - chemistry | Cholesterol, HDL - drug effects | Dietary Carbohydrates - pharmacology | Cholesterol - blood | Humans | Risk Factors | Fatty Acids, Unsaturated - pharmacology | Male | Biomarkers - blood | Lipoproteins - blood | Isomerism | Cardiovascular Diseases - blood | Cholesterol, HDL - blood | Fatty Acids - administration & dosage | Adult | Female | Fatty Acids - pharmacology | Fatty Acids, Unsaturated - administration & dosage | Nutrition | Dietary supplements | Dietary fat | Research | Coronary heart disease | Absorption (Physiology) | Cholesterol | Prevention | Proteolipids | Lipoproteins | Risk factors (Health) | Analysis | Physiological aspects | Causes of | Serum | Health aspects | Index Medicus | Abridged Index Medicus | hydrogenated soybean oil | density-lipoprotein-cholesterol | sunflower oil | coronary heart-disease | stearic-acid | healthy-young men | palmitic acid | plasma-lipids | trans-fatty | normolipidemic men
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 06/2013, Volume 85, Issue 11, pp. 1575 - 1578
Journal Article
American Heart Journal, ISSN 0002-8703, 2017, Volume 187, pp. 182 - 190
Background Patients with prior vascular disease remain at high risk of cardiovascular events despite intensive statin-based treatment. Inhibition of... 
Cardiovascular | LDL CHOLESTEROL | CARDIAC & CARDIOVASCULAR SYSTEMS | ESTER TRANSFER PROTEIN | STATIN THERAPY | HIGH-RISK | FOLLOW-UP | HDL CHOLESTEROL | OUTCOMES | CORONARY-HEART-DISEASE | INHIBITOR ANACETRAPIB | 11-YEAR MORTALITY | Double-Blind Method | Cholesterol, HDL - drug effects | Humans | Middle Aged | Cholesterol, LDL - drug effects | Male | Oxazolidinones - adverse effects | Anticholesteremic Agents - adverse effects | Oxazolidinones - therapeutic use | Coronary Disease - prevention & control | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Intention to Treat Analysis | Cholesterol, HDL - blood | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Research Design | Atorvastatin Calcium - therapeutic use | Clinical trials | Medicine, Experimental | Blood circulation disorders | Medical research | Low density lipoproteins | Cardiovascular agents | Coronary heart disease | Epidemiology | Blood cholesterol | Coronary artery bypass | Diabetes | Trans fatty acids | Statins | Myocardial infarction | Lipoproteins (low density) | Evaluation | Diabetes mellitus | Health risks | Lipids | Cardiovascular disease | Low density lipoprotein | Coronary artery disease | Cholesterol | Cholesteryl ester transfer protein | Recruitment | Motivation | Safety engineering | Arteriosclerosis | Atorvastatin | Cardiovascular diseases | Health risk assessment | Heart diseases | Lipoproteins (high density) | Index Medicus | Abridged Index Medicus | Trial Design
Journal Article